Stark Foreign Tax Credit Bill Would Open Fifth Front In Rx Pricing Debate
Executive Summary
Rep. Stark (D-Calif.) will attempt to open a fifth front in the 2000 legislative debate over pharmaceutical pricing with a bill to deny foreign tax credits to companies that charge higher prices in the U.S. than in other industrialized countries.